Strains of Sindbis virus differ in their virulence for mice of different ages; this variation is related in large part to variations in the amino acid compositions of El and E2, the surface glycoproteins. The comparative pathogenesis of Sindbis virus strains which are virulent or avirulent for newborn mice has not been previously examined. We have studied the diseases caused by a virulent wild-type strain, AR339, and two less virulent laboratory strains, TotollOl and HRSP (HR small plaque). After peripheral inoculation of 1,000 PFU, AR339 Interferon induction parallels virus growth. Mice infected with HRSP develop persistent central nervous system infection (106 PFU/g of brain) until the initiation of a virus-specific immune response 7 to 8 days after infection when virus clearance begins. The distribution of virus in the brains of mice was similar, but the virus was more abundant in the case of AR339. HRSP continued to spread until day 9. Clearance from the brain was complete by day 17. We conclude that the decreased virulence of HRSP is due to an intrinsic decreased ability of this strain of Sindbis virus to grow in neural cells of the mouse. We also conclude that CD-1 mice do not respond to the antigens of Sindbis virus until approximately 1 week of age. This lack of response does not lead to tolerance and persistent infection but rather to late virus clearance whenever the immune response is initiated.
Interferon induction parallels virus growth. Mice infected with HRSP develop persistent central nervous system infection (106 PFU/g of brain) until the initiation of a virus-specific immune response 7 to 8 days after infection when virus clearance begins. The distribution of virus in the brains of mice was similar, but the virus was more abundant in the case of AR339. HRSP continued to spread until day 9. Clearance from the brain was complete by day 17. We conclude that the decreased virulence of HRSP is due to an intrinsic decreased ability of this strain of Sindbis virus to grow in neural cells of the mouse. We also conclude that CD-1 mice do not respond to the antigens of Sindbis virus until approximately 1 week of age. This lack of response does not lead to tolerance and persistent infection but rather to late virus clearance whenever the immune response is initiated.
Sindbis virus (SV), an alphavirus, is relatively nonpathogenic for its various hosts. In humans, infection is often inapparent but occasionally causes arthritis and a rash (7, 18) . In mice, infection predictably causes acute encephalitis, but mortality is age dependent (15, 25) . Although arthritis in humans may be prolonged or recurrent, there is no evidence that this is due to persistent infection (20) . Most wild-type SV isolates, including the prototype AR339 strain, produce an acute, fatal encephalitis in newborn mice and an acute, but nonfatal, monophasic encephalitis in 4-week-old mice (25, 33, 36) . However, laboratory strains of SV derived from wild-type isolates may demonstrate reduced virulence for newborn mice (21) . For instance, the frequently studied HR (heat-resistant) strain of SV, derived from AR339 by Burge and Pfefferkorn in 1965 (3), does not cause uniformly fatal disease in newborn mice (17) .
Previous studies have shown that the laboratory strains HRSP (HR small plaque) and TotollOl, derived from a genetically engineered full-length cDNA clone of SV (26) , are both relatively avirulent for newborn mice after subcutaneous (s.c.) inoculation. Mice often recover from infection, and when infection is fatal, death occurs on average 1 to 2 weeks rather than 3 to 5 days after infection (17, 22 Antibody measurements. Antibody to SV was measured by enzyme immunoassay essentially as previously described (29) . In brief, polystyrene plates were coated with polyethylene glycol-precipitated SV (3 ,ug per well), blocked with 5% fetal bovine serum, incubated with serially diluted serum and then with horseradish peroxidase-conjugated rabbit antimouse immunoglobulin (dilution, 1:200; Dako Corp., Santa Barbara, Calif.), and developed with o-phenylenediamine (Sigma Chemical Co., St. Louis, Mo.), and optical density was read at 490 nm. Samples were run in triplicate, and the titer was expressed as the highest dilution of serum with an optical density greater than two standard deviations above that obtained with normal mouse serum.
Pathology. Brains from mice infected with AR339 were taken on day 2 after infection, and brains from mice infected with HRSP were taken on days 2, 5, 7, 9, 11, 15, 17, 19 , and 21 after infection. Tissue was fixed in 10% buffered Formalin, embedded in paraffin, sectioned sagittally, and stained with hematoxylin and eosin for evaluation of the inflammatory response. Inflammation was graded on a 0-to-4+ scale as previously described (12) . Additional adjacent sections were cut for immunohistochemistry and in situ hybridization studies.
Immunohistochemistry and in situ hybridization. Immunoperoxidase staining for SV antigen was performed as previously described (13) by the avidin-biotin system with rabbit anti-SV antibody as the primary reagent. In situ hybridization was performed essentially as previously described (5, 14) with 35S-labeled anti-sense RNA (specific activity, 9 x 108 dpm/,g) transcribed with SP6 polymerase (Stratagene Inc., La Jolla, Calif.) from a DNA construct encoding the structural genes of SV. Slides were developed 4 days after coating with NTB2 emulsion (Eastman Kodak Co., Rochester, N.Y.), stained with hematoxylin, and examined by bright-field and dark-field microscopy.
Statistics. The significance of differences in mean day of standard error of the mean) of 10.5 + 1.3 and 7.6 + 0.7 (P = 0.048), respectively, compared with 100% mortality and a mean day of death of 4.5 ± 0.2 for AR339 (P < 0.0001 for HRSP; P < 0.001 for TotollOl). To determine whether HRSP and TotollOl would also be avirulent for newborn mice if the brain were infected primarily rather than secondarily, mice were also inoculated with each virus i.c. (Fig. 1) . TotollO1 was only slightly less virulent than AR339 by this route, with 100% mortality and mean days of death of 4.3 ± 0.2 and 3.7 ± 0.2, respectively (P = 0.03). In contrast, HRSP remained comparatively avirulent after i.c. inoculation, with only 75% mortality after 14 days and a mean day of death of 7.8 ± 1.3 (P = 0.02 for TotollO1; P < 0.001 for AR339). These relative differences were confirmed by determining the i.c. and s.c. 50% lethal doses for each virus strain (Table  2) . Subsequent studies were performed by i.c. inoculation.
Virus growth. The replication of virus in the brains of mice after i.c. infection was measured (Fig. 2) . All three strains initiated new virus formation within 4 h of infection. Growth rates were similar up to 9 h, although TotollOl had the highest yield at each point during this time. At 9 h after infection, amounts of TotollO1 and AR339 continued to increase to 108 to 109 PFU/g of brain, while amounts of HRSP plateaued at approximately 106 PFU/g of brain. Except for a transient increase to 107 PFU/g 36 h after infection, levels of HRSP of about 106 PFU/g were maintained until 8 days after infection, at which time virus clearance began (Fig. 3) . The virus was not detectable by routine assay of brain homogenates after day 10. Many, though not all, of the HRSP-induced deaths occurred during the first 7 to 8 days after infection when virus replication was ongoing (Fig. 1) .
Interferon induction. To determine whether early induction of interferon might account for the attenuation of HRSP replication, brain homogenates were assayed for interferon activity (Fig. 4) . Interferon was first detected at 12 h in brains from mice infected with TotollOl, 16 h for AR339, and 20 h for HRSP. In general, interferon levels paralleled virus titers and at 24 h were high for all virus strains, suggesting that interferon was not the primary factor limiting the initial phase of virus replication in HRSP-infected mice. However, interferon was maintained at a relatively high level (dilutions of 1:64 to 1:256) in the brains of HRSPinfected mice through day 9 and may have had a moderating effect on later virus replication and spread within the central nervous system. Immune response. To determine whether newborn mice infected with HRSP developed an immune response to virus infection and whether this correlated with eventual virus clearance, SV-specific antibody was measured by enzyme immunoassay and cellular immunity was evaluated by the appearance of mononuclear inflammatory cells in the brain (19) (Fig. 3) . Both antibody to SV and inflammation were first detected 7 days after infection, coincident with the beginning of virus clearance from the brain. The time course of the immune response was similar after s.c. inoculation of Virus localization. Differences in virulence might be explained by differences in tropism of HRSP and AR339 for cells of the central nervous system. To assess this possibility, brains were stained by immunoperoxidase to localize viral antigen (data not shown) and by in situ hybridization to localize viral nucleic acid (Fig. 5) . No viral antigen or RNA was detected in the brains of uninfected animals. On day 2, viral antigen and RNA were abundant in HRSP-infected mice. Foci of infected cells were found in the cerebral cortex, cerebellum, hippocampus, thalamus, and brain stem as well as nearby muscle. The distribution of viral antigen and RNA was similar in mice infected with AR339, which had more abundant virus in each of the infected areas (Fig.  5A) . On days 5 and 7 after HRSP infection, the virus was widely distributed in the thalamus, brain stem, colliculus, and cortex (Fig. 5B) . By day 9, viral antigen was difficult to locate, but viral RNA could still be readily identified by in situ hybridization through day 15 (Fig. 5C and D) a slow immune response to viral antigen. These studies suggest a fundamental difference in the ability of the HRSP strain of SV to replicate in neural tissue rather than a difference in induction of host responses.
Rapid induction of interferon has been suggested as a mechanism of decreased virulence on the basis of comparisons of plaque variants of SV (23) . In one study, a largeplaque strain of AR339 was less virulent and induced interferon more rapidly than a small-plaque strain did (23) . However, we found that interferon was slower to appear in the brains of mice infected i.c. with avirulent HRSP than with virulent TotollOl or AR339. In general, as previously reported for other SV systems (11, 25, 35) , the amount of interferon in the brain correlated with the amount of virus present. Interferon may, however, account for the failure of HRSP to continue to increase in amount in the brains of infected mice after the first 36 h of infection. High levels of interferon are present by 24 h and are maintained throughout the 8 to 9 days of active infection until the specific immune response appears.
The delayed clearance of HRSP from brains of newborn mice is very similar to the delayed clearance of AR339 from the brains of 4-week-old mice immunosuppressed with cyclophosphamide (19). AR339 is not virulent for 4-week-old mice (11, 15) and is normally completely cleared in 6 to 7 days, with the onset of the antiviral immune response occurring 3 to 4 days after infection. Cyclophosphamide immunosuppression delays appearance of the immune response until 7 to 8 days after infection and delays viral clearance until 11 to 12 days after infection, with persistent viral titers of 106 PFU/g of brain until virus clearance begins (19) . In both situations, the amount of virus in the brain never reaches that of the virulent strain (AR339 for newborn or NSV for 4-week-old mice) despite the absence of an immune response. This suggests intrinsic virus-encoded differences in replicative potential, either in the number of cells infected initially, in the amount of virus produced by each infected cell, or in the ability of the virus to spread (Table 1) (17, 22, 31) . Nonstructural-region changes have not yet been identified. TotollOl is relatively avirulent, like HRSP, after s.c. inoculation but, unlike HRSP, is virulent after i.c. inoculation. This suggests that TotollOl has attenuating properties which affect replication at peripheral sites or invasion of the central nervous system from the periphery. Amino acid changes in both El and E2 have been shown to affect the virulence of these viruses for newborn mice (17, 22) . Few of the changes have been independently evaluated for their specific contributions to virulence.
In E2, Arg substituted for Gly at position 172 decreases binding to neuronal cells (P. C. Tucker and D. E. Griffin, unpublished observations) and may contribute to the avirulence of HRSP after i.c. inoculation. In El, the amino acid at position 72 is an important determinant of the pH of fusion of the viral membrane with the cell membrane, with Ala requiring a lower pH than Val at this position (2), and could potentially alter the efficiency of entry of TotollOl and HRSP into cells. The change from Ala to Ser at position 237 in El appears to be important for age-dependent virulence after s.c. inoculation (17) , but the mechanism has not been identified. Important differences in the nonstructural region are documented for virulence in weanling mice (17) and cannot be ruled out as important for newborn mice as well. Further detailed analysis of the molecular basis for these differences in virulence will depend on further construction of recombinant viruses differing at only a single position.
Newborn mice do not mount an immune response to SV until approximately 7 days of age, suggesting that the immunologic repertoire of T or B lymphocytes does not include the relevant variable-region rearrangements until that age. Previous studies of the role of the immune response in the age-dependent mortality of AR339 infection in mice have shown that fully susceptible 1-week-old mice develop virusspecific antibody and cellular immunity 3 to 4 days after infection, as rapidly as resistant older mice (9) . The relatively low level of HRSP replication does not account for the late antibody development, since AR339 replicates to similar levels (106 to 107 PFU/g of brain) in 4-week-old mice which develop antibody by 3 to 4 days after infection (9, 25) . Many other antigens also are not in the murine repertoire at birth but are acquired in a patterned and reproducible fashion during the first weeks of life (8, 16, 27, 28, 30 
